Literature DB >> 19969371

A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour.

Mika Ito1, Akitoshi Nakashima, Takao Hidaka, Motonori Okabe, Nguyen Duy Bac, Shihomi Ina, Satoshi Yoneda, Arihiro Shiozaki, Shigeki Sumi, Koichi Tsuneyama, Toshio Nikaido, Shigeru Saito.   

Abstract

Chorioamnionitis (CAM) is a major cause of preterm delivery. Inflammatory cytokines and chemokines play important roles in the pathogenesis of preterm delivery. Interleukin (IL)-17 is a key cytokine which induces inflammation and is critical to host defense. In this study, we examined the role of IL-17 in the pathogenesis of preterm delivery. The levels of cytokines including IL-17, IL-8 and tumor necrosis factor (TNF) alpha were measured by ELISA in amniotic fluid from 154 cases of preterm labor. Flow cytometry and immunohistochemical staining were performed to determine the distribution of IL-17-producing cells. IL-8 secretion was evaluated in primary cultured human amniotic mesenchymal (HAM) cells and human amniotic epithelial (HAE) cells stimulated with IL-17, TNFalpha or IL-1beta. We also studied the signaling pathway of IL-17 and TNFalpha in HAM cells. Levels of inflammatory cytokines in amniotic fluid were higher in preterm delivery cases than in term delivery cases. Furthermore, IL-8, IL-17 and TNFalpha levels were significantly higher in the preterm cases with CAM stage II or III than those without CAM. Flow cytometry and immunohistochemical staining revealed that CD3(+)CD4(+) T cells were the main source of IL-17 in the chorioamniotic membrane. Interestingly, TNFalpha-induced IL-8 secretion was enhanced by IL-17 in a dose-dependent manner in HAM cells. The IKK inhibitor BMS-345541 and mitogen-activated protein kinase (MAPK) inhibitors p38, JNK and p42/44 (ERK1/2 pathway) reduced IL-8 secretion by IL-17-stimulated and TNFalpha-stimulated HAM cells. These results indicate that IL-17, produced by T cells, promotes inflammation at the fetomaternal interface in preterm delivery. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19969371     DOI: 10.1016/j.jri.2009.09.005

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  47 in total

Review 1.  Maternal Stroke: an Update.

Authors:  Maria D Zambrano; Eliza C Miller
Journal:  Curr Atheroscler Rep       Date:  2019-06-22       Impact factor: 5.113

2.  Interleukin-1 in lipopolysaccharide induced chorioamnionitis in the fetal sheep.

Authors:  Clare A Berry; Ilias Nitsos; Noah H Hillman; J Jane Pillow; Graeme R Polglase; Boris W Kramer; Matthew W Kemp; John P Newnham; Alan H Jobe; Suhas G Kallapur
Journal:  Reprod Sci       Date:  2011-04-14       Impact factor: 3.060

3.  An imbalance between innate and adaptive immune cells at the maternal-fetal interface occurs prior to endotoxin-induced preterm birth.

Authors:  Marcia Arenas-Hernandez; Roberto Romero; Derek St Louis; Sonia S Hassan; Emily B Kaye; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2015-04-06       Impact factor: 11.530

Review 4.  The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.

Authors:  Lauren M Osborne; Amitoj Brar; Sabra L Klein
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

5.  The majority of murine γδ T cells at the maternal-fetal interface in pregnancy produce IL-17.

Authors:  Gabriela V Pinget; Theresa M Corpuz; Jessica Stolp; Erin L Lousberg; Kerrilyn R Diener; Sarah A Robertson; Jonathan Sprent; Kylie E Webster
Journal:  Immunol Cell Biol       Date:  2016-05-31       Impact factor: 5.126

Review 6.  TH17 cells in human recurrent pregnancy loss and pre-eclampsia.

Authors:  Binqing Fu; Zhigang Tian; Haiming Wei
Journal:  Cell Mol Immunol       Date:  2014-07-14       Impact factor: 11.530

Review 7.  The Fetal-Maternal Immune Interface in Uterus Transplantation.

Authors:  Jasper Iske; Abdallah Elkhal; Stefan G Tullius
Journal:  Trends Immunol       Date:  2020-03       Impact factor: 16.687

8.  Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: A marker of allograft rejection.

Authors:  Eli Maymon; Roberto Romero; Gaurav Bhatti; Piya Chaemsaithong; Nardhy Gomez-Lopez; Bogdan Panaitescu; Noppadol Chaiyasit; Percy Pacora; Zhong Dong; Sonia S Hassan; Offer Erez
Journal:  J Perinat Med       Date:  2018-02-23       Impact factor: 1.901

Review 9.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

10.  IL-17 producing innate lymphoid cells 3 (ILC3) but not Th17 cells might be the potential danger factor for preeclampsia and other pregnancy associated diseases.

Authors:  Prince A Barnie; Xin Lin; Yueqin Liu; Huaxi Xu; Zhaoliang Su
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.